Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

Global Type 1 Diabetes Drugs Market 2019-2023

Technavio has been monitoring the global type 1 diabetes drugs market since 2016 and the market is poised to grow by USD 12 billion during 2019-2023, progressing at a CAGR of over 7% during the forecast period. Read the 127-page research report with TOC on "Type 1 Diabetes Drugs Market Analysis Report by Product (Long-acting insulins, Rapid-acting insulins, Pre-mixed insulins, and Non-insulin drugs), by Geography (Asia, Europe, North America, and ROW), and Segment Forecasts, 2019 - 2023." People who experience mutations in the genes encoding the human leukocyte antigen (HLA) such as the HLA-DQA1, HLA-DQB1, and HLA-DRB1 genes are also susceptible to type 1 diabetes. Major Five Type 1 Diabetes Drugs Market Companies:. Astellas Pharma. Astellas Pharma is headquartered in Japan and operates the business under the Pharmaceuticals segment.

First found on: And then on: 2 other references

2 other references